Welcome to LookChem.com Sign In|Join Free
  • or
8-tert-Butyl 1-methyl (2S)-2-{[(benzyloxy)carbonyl]amino}octanedioate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

891270-72-7

Post Buying Request

891270-72-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

891270-72-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 891270-72-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,1,2,7 and 0 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 891270-72:
(8*8)+(7*9)+(6*1)+(5*2)+(4*7)+(3*0)+(2*7)+(1*2)=187
187 % 10 = 7
So 891270-72-7 is a valid CAS Registry Number.

891270-72-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 8-tert-Butyl 1-methyl (2S)-2-{[(benzyloxy)carbonyl]amino}octanedioate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:891270-72-7 SDS

891270-72-7Relevant academic research and scientific papers

Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors

-

Page/Page column 90, (2009/03/07)

The present invention relates to compounds of formula I: or pharmaceutically acceptable salts or tautomers thereof, which are inhibitors of histone deacetylase (HDAC). The compounds of the present invention are useful for treating cellular proliferative diseases, including cancer. Further, the compounds of the present invention are useful for treating neurodegenerative diseases, schizophrenia and stroke among other diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 891270-72-7